Literature DB >> 11920761

Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits.

Yuyan Jiao1, Nathalie Ubrich, Valérie Hoffart, Monique Marchand-Arvier, Claude Vigneron, Maurice Hoffman, Philippe Maincent.   

Abstract

Heparin-loaded microparticles, prepared according to the double emulsion method with biodegradable (PCL and PLGA) and nonbiodegradable (Eudragit RS and RL) polymers used alone or in combination, with or without gelatin, were characterized in vitro and in vivo after oral administration in rabbits. The entrapment efficiency and the release of heparin were determined by a colorimetric method with Azure II. The antifactor Xa activity of heparin released in vitro after 24 h was assessed. After oral administration of heparin-loaded microparticles in rabbits, the time course of modification of the clotting time estimated by the activated partial thromboplastin time (APTT) was followed over 24 h. Microparticles with a size ranging from 80 to 280 microm were obtained. Heparin entrapment efficiency as well as heparin release depended on both the nature of the polymers and the presence of gelatin. The Eudragit polymers increased the drug loading but slowed down the heparin release, whereas gelatin accelerated the release. No change in clotting time was observed after oral administration of gelatin microparticles. Heparin-loaded microparticles prepared with blends of PLGA and Eudragit displayed a prolonged duration of action characterized by a twofold increase in APTT and a enhancement of absorption. This study demonstrated the feasibility of encapsulating heparin within polymeric particles, and the significant increase in APTT confirmed the oral absorption of heparin released from polymeric microparticles. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920761     DOI: 10.1002/jps.10097

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route.

Authors:  Yiwei Qi; Ganlin Zhao; Dongfang Liu; Zachary Shriver; Mallik Sundaram; Shiladitya Sengupta; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-29       Impact factor: 11.205

2.  Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates.

Authors:  Angela Viehof; Alf Lamprecht
Journal:  Pharm Res       Date:  2013-05-07       Impact factor: 4.200

3.  Study of the micellization behavior of different order amino block copolymers with heparin.

Authors:  Marie-Hélène Dufresne; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

4.  Papain: an effective permeation enhancer for orally administered low molecular weight heparin.

Authors:  Vjera Grabovac; Thierry Schmitz; Florian Föger; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

5.  Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.

Authors:  Eleonora Truzzi; Chiara Bongio; Francesca Sacchetti; Eleonora Maretti; Monica Montanari; Valentina Iannuccelli; Elena Vismara; Eliana Leo
Journal:  Molecules       Date:  2017-06-09       Impact factor: 4.411

6.  Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes.

Authors:  Sandy Gim Ming Ong; Long Chiau Ming; Kah Seng Lee; Kah Hay Yuen
Journal:  Pharmaceutics       Date:  2016-08-26       Impact factor: 6.321

Review 7.  Strategies to Overcome Heparins' Low Oral Bioavailability.

Authors:  Ana Rita Neves; Marta Correia-da-Silva; Emília Sousa; Madalena Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.